Literature DB >> 20182612

Ubiquitination and degradation of the inhibitors of NF-kappaB.

Naama Kanarek1, Nir London, Ora Schueler-Furman, Yinon Ben-Neriah.   

Abstract

The key step in NF-kappaB activation is the release of the NF-kappaB dimers from their inhibitory proteins, achieved via proteolysis of the IkappaBs. This irreversible signaling step constitutes a commitment to transcriptional activation. The signal is eventually terminated through nuclear expulsion of NF-kappaB, the outcome of a negative feedback loop based on IkappaBalpha transcription, synthesis, and IkappaBalpha-dependent nuclear export of NF-kappaB (Karin and Ben-Neriah 2000). Here, we review the process of signal-induced IkappaB ubiquitination and degradation by comparing the degradation of several IkappaBs and discussing the characteristics of IkappaBs' ubiquitin machinery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20182612      PMCID: PMC2828279          DOI: 10.1101/cshperspect.a000166

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  119 in total

1.  I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity.

Authors:  S T Whiteside; J C Epinat; N R Rice; A Israël
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

Review 2.  The SCF ubiquitin ligase: insights into a molecular machine.

Authors:  Timothy Cardozo; Michele Pagano
Journal:  Nat Rev Mol Cell Biol       Date:  2004-09       Impact factor: 94.444

3.  F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex.

Authors:  D Skowyra; K L Craig; M Tyers; S J Elledge; J W Harper
Journal:  Cell       Date:  1997-10-17       Impact factor: 41.582

4.  The 90-kDa ribosomal S6 kinase (pp90rsk) phosphorylates the N-terminal regulatory domain of IkappaBalpha and stimulates its degradation in vitro.

Authors:  L Ghoda; X Lin; W C Greene
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

5.  IkappaB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase.

Authors:  G J Schouten; A C Vertegaal; S T Whiteside; A Israël; M Toebes; J C Dorsman; A J van der Eb; A Zantema
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

6.  SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box.

Authors:  C Bai; P Sen; K Hofmann; L Ma; M Goebl; J W Harper; S J Elledge
Journal:  Cell       Date:  1996-07-26       Impact factor: 41.582

7.  Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice.

Authors:  A A Beg; W C Sha; R T Bronson; D Baltimore
Journal:  Genes Dev       Date:  1995-11-15       Impact factor: 11.361

8.  NF-kappaB functions as a tumour promoter in inflammation-associated cancer.

Authors:  Eli Pikarsky; Rinnat M Porat; Ilan Stein; Rinat Abramovitch; Sharon Amit; Shafika Kasem; Elena Gutkovich-Pyest; Simcha Urieli-Shoval; Eithan Galun; Yinon Ben-Neriah
Journal:  Nature       Date:  2004-08-25       Impact factor: 49.962

9.  Induction of p100 processing by NF-kappaB-inducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation.

Authors:  Gutian Xiao; Abraham Fong; Shao-Cong Sun
Journal:  J Biol Chem       Date:  2004-05-11       Impact factor: 5.157

10.  The same IkappaBalpha mutation in two related individuals leads to completely different clinical syndromes.

Authors:  Riny Janssen; Annelies van Wengen; Marieke A Hoeve; Monique ten Dam; Miriam van der Burg; Jacques van Dongen; Esther van de Vosse; Maarten van Tol; Robbert Bredius; Tom H Ottenhoff; Corry Weemaes; Jaap T van Dissel; Arjan Lankester
Journal:  J Exp Med       Date:  2004-08-30       Impact factor: 14.307

View more
  54 in total

1.  Specific recognition of linear ubiquitin chains by the Npl4 zinc finger (NZF) domain of the HOIL-1L subunit of the linear ubiquitin chain assembly complex.

Authors:  Yusuke Sato; Hiroaki Fujita; Azusa Yoshikawa; Masami Yamashita; Atsushi Yamagata; Stephen E Kaiser; Kazuhiro Iwai; Shuya Fukai
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-02       Impact factor: 11.205

2.  Cadmium and Secondary Structure-dependent Function of a Degron in the Pca1p Cadmium Exporter.

Authors:  Nathan Smith; Wenzhong Wei; Miaoyun Zhao; Xiaojuan Qin; Javier Seravalli; Heejeong Kim; Jaekwon Lee
Journal:  J Biol Chem       Date:  2016-04-08       Impact factor: 5.157

Review 3.  The role of aberrant proteolysis in lymphomagenesis.

Authors:  Anagh A Sahasrabuddhe; Kojo S J Elenitoba-Johnson
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

Review 4.  Tumor necrosis factor receptor-associated factor 6 as a nuclear factor kappa B-modulating therapeutic target in cardiovascular diseases: at the heart of it all.

Authors:  Muhammad Abdullah; Jessica M Berthiaume; Monte S Willis
Journal:  Transl Res       Date:  2017-11-07       Impact factor: 7.012

Review 5.  Molecular Mechanisms of Innate Immune Inhibition by Non-Segmented Negative-Sense RNA Viruses.

Authors:  Srirupa Chatterjee; Christopher F Basler; Gaya K Amarasinghe; Daisy W Leung
Journal:  J Mol Biol       Date:  2016-07-31       Impact factor: 5.469

6.  A three-part signal governs differential processing of Gli1 and Gli3 proteins by the proteasome.

Authors:  Erin K Schrader; Kristine G Harstad; Robert A Holmgren; Andreas Matouschek
Journal:  J Biol Chem       Date:  2011-09-15       Impact factor: 5.157

Review 7.  Signaling cross-talk in the resistance to HER family receptor targeted therapy.

Authors:  H Yamaguchi; S-S Chang; J L Hsu; M-C Hung
Journal:  Oncogene       Date:  2013-04-01       Impact factor: 9.867

Review 8.  Signaling in innate immunity and inflammation.

Authors:  Kim Newton; Vishva M Dixit
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-03-01       Impact factor: 10.005

Review 9.  Human IκBα Gain of Function: a Severe and Syndromic Immunodeficiency.

Authors:  Bertrand Boisson; Anne Puel; Capucine Picard; Jean-Laurent Casanova
Journal:  J Clin Immunol       Date:  2017-06-09       Impact factor: 8.317

10.  T cell receptor/CARMA1/NF-κB signaling controls T-helper (Th) 17 differentiation.

Authors:  Luciana L Molinero; Alan Cubre; Carolina Mora-Solano; Ying Wang; Maria-Luisa Alegre
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.